Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

FDA Phase IV - Commitment - Retinal Function Study

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT00461565
First received: April 17, 2007
Last updated: March 18, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Estimated Primary Completion Date: No date given